Can pharma tariffs “Make America Manufacture Again”?
As President Trump continues to signal import tariffs on pharmaceuticals to bolster US manufacturing, experts warn this could hike costs…
Analysis
Power of collaboration more pertinent than ever says pharma experts
Newborn screening strategy needs modernising as HHS disbands advisory committee
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
Introducing the Pharmaceutical Technology Excellence Awards 2025
Entering the era of prenatal gene therapies
Magazine: The GLP-1 shortage is over. What’s next for compounders?
